Stefano PEPE | Pubblicazioni

53317A phase I-II trial of gefitinib (IRESSA) and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)

	2005
	Abstract in rivista
	A phase I-II trial of gefitinib (IRESSA) and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN) EUROPEAN JOURNAL OF CANCER. SUPPLEMENT. Vol. 3. Pag.313-313 ISSN:1359-6349.
	F., Caponigro; G., Franchin; V., Rav; G., Silvestro; B., Morrica; C., Romano; E., Minatel; Pepe, Stefano
	Visualizza sul Database dei Prodotti (IRIS)

53031POLY(ADENOSINE DIPHOSPHATE-RIBOSE) POLYMERASE 1 EXPRESSION IN MALIGNANT MELANOMAS FROM PHOTOEXPOSED AREAS OF THE HEAD AND NECK REGION.

	2005
	Articolo in rivista
	POLY(ADENOSINE DIPHOSPHATE-RIBOSE) POLYMERASE 1 EXPRESSION IN MALIGNANT MELANOMAS FROM PHOTOEXPOSED AREAS OF THE HEAD AND NECK REGION. HUMAN PATHOLOGY. Vol. 36. Pag.724-731 ISSN:0046-8177.
	S., Staibano; Pepe, Stefano; L., LO MUZIO; P., Somma; M., Mascolo; G., Argenziano; M., Scalvenzi; G., Salvatore; G., Fabbrocini; G., Molea; A. R., Bianco; C., Carlomagno; G., DE ROSA
	Digital Object Identifier (DOI): 10.1016/J.HUMPATH.2005.04.017 Codice identificativo ISI: WOS:000231305800005 Codice identificativo SCOPUS: 2-s2.0-23444443380
	Visualizza sul Database dei Prodotti (IRIS)

39439Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors.

	2005
	Articolo in rivista
	Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors. ANNALS OF ONCOLOGY. Vol. 16. Pag.iv61-iv68 ISSN:0923-7534.
	M. P., Morelli; T., Cascone; T., Troiani; F., DE VITA; M., Orditura; G., Laus; S. G., Eckhardt; Pepe, Stefano; G., Tortora; F., Ciardiello
	Codice identificativo ISI: WOS:000202969900011 Codice identificativo SCOPUS: 2-s2.0-30444445564
	Visualizza sul Database dei Prodotti (IRIS)

39434A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients.

	2005
	Articolo in rivista
	A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. BRITISH JOURNAL OF CANCER. Vol. 92. Pag.1644-1649 ISSN:0007-0920.
	F., DE VITA; M., Orditura; E., Matano; R., Bianco; C., Carlomagno; S., Infusino; V., Damiano; E., Simeone; M. R., Diadema; E., Lieto; P., Castellano; Pepe, Stefano; S., DE PLACIDO; G., Galizia; N., DI MARTINO; F., Ciardiello; G., Catalano; A. R., Bianco
	Codice identificativo ISI: WOS:000228863500009 Codice identificativo SCOPUS: 2-s2.0-21144476975
	Visualizza sul Database dei Prodotti (IRIS)